These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19616656)

  • 1. Re: "Effect of long-term treatment with strontium ranelate on bone strontium content" by Bärenholdt et al. (Bone, 2009).
    Belissa-Chatelain P; Dupin-Roger I; Cournarie F; Tsouderos Y
    Bone; 2009 Nov; 45(5):1024-5; author reply 1026-7. PubMed ID: 19616656
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effect of strontium ranelate treatment on BMD.
    Blake GM; Fogelman I
    J Bone Miner Res; 2005 Nov; 20(11):1901-4. PubMed ID: 16234961
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of long-term treatment with strontium ranelate on bone strontium content.
    Bärenholdt O; Kolthoff N; Nielsen SP
    Bone; 2009 Aug; 45(2):200-6. PubMed ID: 19376283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 5. Strontium ranelate improves bone microarchitecture in osteoporosis.
    Hamdy NA
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
    Middleton ET; Steel SA; Aye M; Doherty SM
    J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
    Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
    J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.
    Busse B; Jobke B; Hahn M; Priemel M; Niecke M; Seitz S; Zustin J; Semler J; Amling M
    Acta Biomater; 2010 Dec; 6(12):4513-21. PubMed ID: 20654744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
    Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
    J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
    Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
    N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium as therapy for osteoporosis.
    Marie PJ
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
    Manette C; Collette J; Sarlet N; Tancredi A; Zegels B; Reginster JY
    Curr Med Chem; 2006; 13(13):1585-90. PubMed ID: 16787205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
    Rolland Y; Abellan Van Kan G; Gillette-Guyonnet S; Roux C; Boonen S; Vellas B
    Bone; 2011 Feb; 48(2):332-8. PubMed ID: 20817053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strontium Ranelate as a new therapeutic agent for osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2005 Jan; 15(1):25-8. PubMed ID: 15632469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM
    Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical model for the interpretation of BMD scans in patients stopping strontium ranelate treatment.
    Blake GM; Fogelman I
    J Bone Miner Res; 2006 Sep; 21(9):1417-24. PubMed ID: 16939400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correction of BMD measurements for bone strontium content.
    Blake GM; Fogelman I
    J Clin Densitom; 2007; 10(3):259-65. PubMed ID: 17543560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium ranelate normalizes bone mineral density in osteopenic patients.
    Malaise O; Bruyere O; Reginster JY
    Aging Clin Exp Res; 2007 Aug; 19(4):330-3. PubMed ID: 17726365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.
    Marie PJ
    Mol Interv; 2010 Oct; 10(5):305-12. PubMed ID: 21045244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment.
    Li C; Paris O; Siegel S; Roschger P; Paschalis EP; Klaushofer K; Fratzl P
    J Bone Miner Res; 2010 May; 25(5):968-75. PubMed ID: 19874195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.